Ursin G, Bernstein L, Pike M C
Department of Preventive Medicine, University of Southern California School of Medicine, Los Angeles 90033.
Cancer Surv. 1994;19-20:241-64.
There is a four to fivefold variation in breast cancer incidence rates across different countries. The lowest rates are observed in Asia, and the highest rates are observed in western Europe and North America. The incidence of breast cancer has increased in all countries since 1960. We studied in detail (whenever possible) the changes in incidence and mortality between 1955 and 1990 in four age groups (35-44, 45-54, 55-64 and 65-74) for 11 "representative" countries (USA, England and Wales, Norway, Hungary, Yugoslavia, Spain, Colombia, Singapore, Japan, India and China). The largest increase in incidence took place in Japan and Singapore. The incidence rate for women aged 35-44 in Japan doubled between 1960 and 1985 and by 1985 was roughly two thirds the USA rate. There has been essentially no change in mortality rates in the USA, England and Wales or Norway, whereas there has been a 50-60% increase in Japan, Singapore and Hungary. Most of the observed increase in incidence rates in the USA, England and Wales and Norway may be "artefactual", that is, due to changes in screening patterns. Screening may also have contributed to the rate increase in other countries, but outside western Europe and North America the major part of the increase is likely to be due to changes in known and suspected breast cancer risk factors.
不同国家的乳腺癌发病率存在4至5倍的差异。亚洲的发病率最低,而西欧和北美的发病率最高。自1960年以来,所有国家的乳腺癌发病率都有所上升。我们尽可能详细地研究了11个“代表性”国家(美国、英格兰和威尔士、挪威、匈牙利、南斯拉夫、西班牙、哥伦比亚、新加坡、日本、印度和中国)在1955年至1990年期间四个年龄组(35 - 44岁、45 - 54岁、55 - 64岁和65 - 74岁)的发病率和死亡率变化。发病率增长最大的是日本和新加坡。日本35 - 44岁女性的发病率在1960年至1985年间翻了一番,到1985年约为美国发病率的三分之二。美国、英格兰和威尔士或挪威的死亡率基本没有变化,而日本、新加坡和匈牙利的死亡率则上升了50%至60%。在美国、英格兰和威尔士以及挪威观察到的发病率增加,大部分可能是“人为造成的”,也就是说,是由于筛查模式的变化。筛查也可能导致了其他国家发病率的上升,但在西欧和北美以外,发病率增加的主要部分可能是由于已知和疑似乳腺癌风险因素的变化。